78 related articles for article (PubMed ID: 9647742)
1. 2-Methoxyestradiol-induced phosphorylation of Bcl-2: uncoupling from JNK/SAPK activation.
Attalla H; Westberg JA; Andersson LC; Adlercreutz H; Mäkelä TP
Biochem Biophys Res Commun; 1998 Jun; 247(3):616-9. PubMed ID: 9647742
[TBL] [Abstract][Full Text] [Related]
2. Serine protease inhibitor TPCK prevents Taxol-induced cell death and blocks c-Raf-1 and Bcl-2 phosphorylation in human breast carcinoma cells.
Huang Y; Sheikh MS; Fornace AJ; Holbrook NJ
Oncogene; 1999 Jun; 18(23):3431-9. PubMed ID: 10376521
[TBL] [Abstract][Full Text] [Related]
3. Bcl-xL is phosphorylated in malignant cells following microtubule disruption.
Poruchynsky MS; Wang EE; Rudin CM; Blagosklonny MV; Fojo T
Cancer Res; 1998 Aug; 58(15):3331-8. PubMed ID: 9699663
[TBL] [Abstract][Full Text] [Related]
4. Microtubule inhibitors elicit differential effects on MAP kinase (JNK, ERK, and p38) signaling pathways in human KB-3 carcinoma cells.
Stone AA; Chambers TC
Exp Cell Res; 2000 Jan; 254(1):110-9. PubMed ID: 10623471
[TBL] [Abstract][Full Text] [Related]
5. Raf-1/bcl-2 phosphorylation: a step from microtubule damage to cell death.
Blagosklonny MV; Giannakakou P; el-Deiry WS; Kingston DG; Higgs PI; Neckers L; Fojo T
Cancer Res; 1997 Jan; 57(1):130-5. PubMed ID: 8988053
[TBL] [Abstract][Full Text] [Related]
6. Selective induction of apoptosis by the pyrrolo-1,5-benzoxazepine 7-[[dimethylcarbamoyl]oxy]-6-(2-naphthyl)pyrrolo-[2,1-d] (1,5)-benzoxazepine (PBOX-6) in Leukemia cells occurs via the c-Jun NH2-terminal kinase-dependent phosphorylation and inactivation of Bcl-2 and Bcl-XL.
Mc Gee MM; Greene LM; Ledwidge S; Campiani G; Nacci V; Lawler M; Williams DC; Zisterer DM
J Pharmacol Exp Ther; 2004 Sep; 310(3):1084-95. PubMed ID: 15143129
[TBL] [Abstract][Full Text] [Related]
7. MAD2-induced sensitization to vincristine is associated with mitotic arrest and Raf/Bcl-2 phosphorylation in nasopharyngeal carcinoma cells.
Wang X; Jin DY; Wong HL; Feng H; Wong YC; Tsao SW
Oncogene; 2003 Jan; 22(1):109-16. PubMed ID: 12527913
[TBL] [Abstract][Full Text] [Related]
8. Modulation of mitogen-activated protein kinases and phosphorylation of Bcl-2 by vinblastine represent persistent forms of normal fluctuations at G2-M1.
Fan M; Du L; Stone AA; Gilbert KM; Chambers TC
Cancer Res; 2000 Nov; 60(22):6403-7. PubMed ID: 11103805
[TBL] [Abstract][Full Text] [Related]
9. Roles of p38- and c-jun NH2-terminal kinase-mediated pathways in 2-methoxyestradiol-induced p53 induction and apoptosis.
Shimada K; Nakamura M; Ishida E; Kishi M; Konishi N
Carcinogenesis; 2003 Jun; 24(6):1067-75. PubMed ID: 12807754
[TBL] [Abstract][Full Text] [Related]
10. Functional interaction between retinoblastoma protein and stress-activated protein kinase in multiple myeloma cells.
Chauhan D; Hideshima T; Treon S; Teoh G; Raje N; Yoshihimito S; Tai YT; Li W; Fan J; DeCaprio J; Anderson KC
Cancer Res; 1999 Mar; 59(6):1192-5. PubMed ID: 10096546
[TBL] [Abstract][Full Text] [Related]
11. p38 Mitogen-activated protein kinases is required for counteraction of 2-methoxyestradiol to estradiol-stimulated cell proliferation and induction of apoptosis in ovarian carcinoma cells via phosphorylation Bcl-2.
Bu SZ; Huang Q; Jiang YM; Min HB; Hou Y; Guo ZY; Wei JF; Wang JW; Ni X; Zheng SS
Apoptosis; 2006 Mar; 11(3):413-25. PubMed ID: 16538384
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of the Raf-MEK1/2-ERK1/2 signaling pathway, Bcl-xL down-regulation, and chemosensitization of non-Hodgkin's lymphoma B cells by Rituximab.
Jazirehi AR; Vega MI; Chatterjee D; Goodglick L; Bonavida B
Cancer Res; 2004 Oct; 64(19):7117-26. PubMed ID: 15466208
[TBL] [Abstract][Full Text] [Related]
13. Bcl-2 regulates nonapoptotic signal transduction: inhibition of c-Jun N-terminal kinase (JNK) activation by IL-1 beta and hydrogen peroxide.
Lee L; Irani K; Finkel T
Mol Genet Metab; 1998 May; 64(1):19-24. PubMed ID: 9682214
[TBL] [Abstract][Full Text] [Related]
14. Mitochondrial targeting of JNK/SAPK in the phorbol ester response of myeloid leukemia cells.
Ito Y; Mishra NC; Yoshida K; Kharbanda S; Saxena S; Kufe D
Cell Death Differ; 2001 Aug; 8(8):794-800. PubMed ID: 11526432
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of BRCA1 leads to increased chemoresistance to microtubule-interfering agents, an effect that involves the JNK pathway.
Lafarge S; Sylvain V; Ferrara M; Bignon YJ
Oncogene; 2001 Oct; 20(45):6597-606. PubMed ID: 11641785
[TBL] [Abstract][Full Text] [Related]
16. Extracellular-regulated kinase 1/2, Jun N-terminal kinase, and c-Jun are involved in NF-kappa B-dependent IL-6 expression in human monocytes.
Tuyt LM; Dokter WH; Birkenkamp K; Koopmans SB; Lummen C; Kruijer W; Vellenga E
J Immunol; 1999 Apr; 162(8):4893-902. PubMed ID: 10202034
[TBL] [Abstract][Full Text] [Related]
17. Berberine induces apoptosis in SW620 human colonic carcinoma cells through generation of reactive oxygen species and activation of JNK/p38 MAPK and FasL.
Hsu WH; Hsieh YS; Kuo HC; Teng CY; Huang HI; Wang CJ; Yang SF; Liou YS; Kuo WH
Arch Toxicol; 2007 Oct; 81(10):719-28. PubMed ID: 17673978
[TBL] [Abstract][Full Text] [Related]
18. Mitogen-activated protein kinase pathway is dispensable for microtubule-active drug-induced Raf-1/Bcl-2 phosphorylation and apoptosis in leukemia cells.
Blagosklonny MV; Chuman Y; Bergan RC; Fojo T
Leukemia; 1999 Jul; 13(7):1028-36. PubMed ID: 10400418
[TBL] [Abstract][Full Text] [Related]
19. Diallyl trisulfide-induced apoptosis in human prostate cancer cells involves c-Jun N-terminal kinase and extracellular-signal regulated kinase-mediated phosphorylation of Bcl-2.
Xiao D; Choi S; Johnson DE; Vogel VG; Johnson CS; Trump DL; Lee YJ; Singh SV
Oncogene; 2004 Jul; 23(33):5594-606. PubMed ID: 15184882
[TBL] [Abstract][Full Text] [Related]
20. The role of activated MEK-ERK pathway in quercetin-induced growth inhibition and apoptosis in A549 lung cancer cells.
Nguyen TT; Tran E; Nguyen TH; Do PT; Huynh TH; Huynh H
Carcinogenesis; 2004 May; 25(5):647-59. PubMed ID: 14688022
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
